Amber Therapeutics is developing Amber-UI, a breakthrough adaptive neuromodulation therapy to treat women suffering with mixed urinary incontinence with the hope of transforming the clinical outcome and quality of life of a large untreated population.

Sectors
Healthcare
Life Sciences
First Invested
2024
Early
Company Status
Private